Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study

Overview of attention for article published in Cancer Management and Research, May 2019

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Reddit Dimensions citations

So far, Dimensions has found 17 publications that cite this research output.

17

The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.

Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality

Article in ACS Central Science (February 2024)

Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC

Article in Cancers (February 2024)

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer

Article in International Journal of Cancer (October 2023)